Neuregulin-1 attenuates mitochondrial dysfunction in a rat model of heart failure

被引:0
|
作者
GUO Yong-fang
机构
关键词
D O I
暂无
中图分类号
R541.6 [血液循环衰竭];
学科分类号
1002 ; 100201 ;
摘要
Background Mitochondrial dysfunction plays a pivotal role in the progression of left ventricular(LV) remodeling and heart failure(HF).Recombinant human neuregulin-1(rhNRG-1) improves cardiac function in models of experimental HF and in clinical trials;however,its impact on mitochondrial function during chronic HF remains largely unknown.The purpose of this study was to investigate whether rhNRG-1 could attenuate the functional and structural changes that occur in cardiac mitochondria in a rat model of HF induced by myocardial infarction. Methods Sixty adult rats underwent sham or coronary ligation to induce HF.Four weeks after ligation,29 animals with LV ejective fraction <50%were randomized to receive either vehicle or rhNRG-1(10μg·kg;·d;,I.V.) for 10 days,another 12 sham-operated animals were given no treatment.Echocardiography was used to determine physiological changes. Mitochondrial membrane potential(MMP),respiratory function and tissue adenosine triphosphate(ATP) production were analyzed.Cytochrome c expression and cardiomyocyte apoptosis were determined.Oxidative stress was evaluated by reactive oxygen species production using fluorescence assays and gene expression of glutathione peroxidase measured by real-time quantitative PCR. Results Compared with sham-operated animals,vehicle treated HF rats exhibited severe LV remodeling and dysfunction,significant mitochondrial dysfunction,increased mitochondrial cytochrome c release,increased myocyte apoptosis and enhanced oxidative stress.Short-term treatment with rhNRG-1 significantly attenuated LV remodeling and cardiac function.Concomitant with this change,mitochondrial dysfunction was significantly attenuated;with ATP production,MMP and respiratory function restored,cytochrome c release and apoptosis inhibited,and oxidative stress reduced. Conclusion The present study demonstrated that rhNRG-1 can significantly improve LV remodeling and cardiac function in the failing heart,this beneficial effect is related to reducing mitochondrial dysfunction,myocyte apoptosis and oxidative stress.
引用
收藏
页码:807 / 814
相关论文
共 50 条
  • [1] Neuregulin-1 attenuates mitochondrial dysfunction in a rat model of heart failure
    Guo Yong-fang
    Zhang Xiao-xia
    Liu Yong
    Duan Hong-yan
    Jie Bing-zhang
    Wu Xue-si
    CHINESE MEDICAL JOURNAL, 2012, 125 (05) : 807 - 814
  • [2] Circulating Neuregulin-1β in Human Heart Failure
    Ky, Bonnie
    Kimmel, Stephen E.
    Safa, Radwan
    Putt, Mary E.
    Sweitzer, Nancy K.
    Fang, James C.
    Sawyer, Douglas B.
    Cappola, Thomas P.
    CIRCULATION, 2009, 119 (10) : E312 - E313
  • [3] Neuregulin-1β for the treatment of systolic heart failure
    Sawyer, Douglas B.
    Caggiano, Anthony
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (04) : 501 - 505
  • [4] Neuregulin-1 promotes mitochondrial biogenesis, attenuates mitochondrial dysfunction, and prevents hypoxia/reoxygenation injury in neonatal cardiomyocytes
    Zhang, Xiao-Xia
    Wu, Xue-Si
    Mi, Shu-Hua
    Fang, Shan-Juan
    Liu, Sa
    Xin, Yi
    Zhao, Quan-Ming
    CELL BIOCHEMISTRY AND FUNCTION, 2020, 38 (05) : 549 - 557
  • [5] Anti-Cachectic Role of Neuregulin-1β in Heart Failure
    Gupte, M.
    Galindo, C.
    Manda, P.
    Cleator, J.
    Murphy, A.
    Kasasbeh, E.
    Sawyer, D.
    FASEB JOURNAL, 2015, 29
  • [6] Neuregulin-1 Attenuates Doxorubicin-induced Autophagy in Neonatal Rat Cardiomyocytes
    An, Tao
    Huang, Yan
    Zhou, Qiong
    Wei, Bing Qi
    Zhang, Rong Cheng
    Yin, Shi Jie
    Zou, Chang Hong
    Zhang, Yu Hui
    Zhang, Jian
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (02) : 130 - 137
  • [7] Neuregulin-1 attenuates doxorubicin-induced autophagy in neonatal rat cardiomyocytes
    An, Tao
    Zhang, Yuhui
    Zhang, Jian
    CARDIOLOGY, 2013, 126 : 76 - 76
  • [8] Neuregulin-1/ErbB signaling: a druggable target for treating heart failure
    Xu, Yabei
    Li, Xinyan
    Zhou, Mingdong
    CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (02) : 214 - 219
  • [9] Utility of Neuregulin-1β in the Diagnosis and Prognosis of Acute Heart Failure Syndrome
    Henry-Okafor, Q.
    Collins, S.
    Jenkins, C.
    Miller, K.
    Maron, D. J.
    Naftilan, A.
    Fermann, G.
    Smith, H. M.
    Peng, X.
    Sawyer, D. B.
    Storrow, A. B.
    ANNALS OF EMERGENCY MEDICINE, 2011, 58 (04) : S304 - S304
  • [10] Association Between Circulating Neuregulin-1β and Clinical Outcomes in Heart Failure
    Ky, Bonnie
    Kimmel, Stephen E.
    Safa, Radwan
    Putt, Mary E.
    Sweitzer, Nancy K.
    Fang, James C.
    Sawyer, Douglas B.
    Cappola, Thomas P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A175 - A175